Albers D. S., Swerdlow R. H., Manfredi G., Gajewski C., Yang L.,
Parker W. D. Jr and Beal M. F. (2001) Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp.
Neurol. 168, 196–198.
Albin R. L. (2000) Basal ganglia neurotoxins. Neurol. Clin. 18, 665–
680.
Beal M. F., Brouillet E., Jenkins B., Ferrante R. J., Kowall N. W., Miller
J. M., Storey E., Srivastava R., Rosen B. R. and Hyman B. T.
(1993) Neurochemical and histological characterization of the
striatal excitotoxic lesions produced by the mitochondrial toxin
3-nitroproprionic acid. J. Neurosci. 13, 1481–1492.
Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V.
and Greenamyre J. T. (2000) Chronic systemic pesticide exposure
reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301–
1306.
Bhatt M. H., Elias M. A. and Mankodi A. K. (1999) Acute and reversible
parkinsonism due to organophosphate pesticide intoxication: five
cases. Neurology 52, 1467–1471.
Bindoff L. A., Birch-Machin M., Cartlidge N. E., Parker W. D. Jr and
Turnbull D. M. (1989) Mitochondrial function in Parkinson's
disease. Lancet 2, 49.
Borlongan C. V., Koutouzis T. K., Freeman T. B., Hauser R. A., Cahill
D. W. and Sanberg P. R. (1997) Hyperactivity and hypoactivity in a
rat model of Huntington's disease: the systemic 3-nitroproprionic
acid model. Brain Res. Protocols 1, 253–257.
Brouillet E., Jenkins B., Hyman B., Ferrante R. J., Kowall N. W.,
Srivastava R., Roy D. S., Rosen B. and Beal M. F. (1993) Agedependent vulnerability of the striatum to the mitochondrial toxin
3-nitropropionic acid. J. Neurochem. 60, 356–359.
Caparros-Lefebvre D. and Elbaz A. (1999) Possible relation of atypical
parkinsonism in the French West Indies with consumption of
tropical plants: a case–control study. Caribbean Parkinsonism
Study Group. Lancet 354, 281–286.
Caparros-Lefebvre D., Sergeant N., Lees A., Camuzat A., Daniel S.,
Lannuzel A., Brice A., Tolosa E., Delacourte A. and Duyckaerts C.
(2002) Guadeloupean parkinsonism: a cluster of progressive su- pranuclear palsy-like tauopathy. Brain 125, 801–811.
Daniel S. E., de Bruin V. M. S. and Lees A. J. (1995) The clinical and
pathological spectrum of Steele–Richardson–Olszewski syndrome
(progressive supranuclear palsy): a reappraisal. Brain 118, 759–770.
DiDonato S., Zeviani M., Giovannini P., Savarese N., Rimoldi M.,
Mariotti C., Girotti F. and Caraceni T. (1993) Respiratory chain and
mitochondrial DNA in muscle and brain in Parkinson's disease
patients. Neurology. 43, 2262–2268.
Ehringer H. and Hornykiewicz O. (1960) Verteilung von Noradrenalin
und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und
ihr Verhalten bei Erkrankungen des extrapyramidalen Systems.
Klin. Wochenschrift 38, 1236–1239.
Fearnley J. M. and Lees A. J. (1990) Striatonigral degeneration. A
clinicopathological study. Brain 113, 1823–1842.
Ferrante R. J., Schulz J. B., Kowall N. W. and Beal M. F. (1997) Systemic administration of rotenone produces selective damage in the
striatum and globus pallidus, but not in the substantia nigra. Brain
Res. 753, 157–162.
Glinka Y. Y. and Youdim M. B. (1995) Inhibition of mitochondrial
complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol.
292, 329–332.
Guyot M.-C., Hantraye P., Dolan R., Palfi S., Maziere M. and Brouillet
E. (1997) Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with
3-nitropropionic acid. Neuroscience 79, 45–56.
Hamilton B. F. and Gould D. H. (1987) Nature and distribution of brain
lesions in rats intoxicated with 3-nitropropionic acid: a type of
